TARDBP and amyotrophic lateral sclerosis: We validated two of the skiptic exons in fibroblasts derived from patients carrying TARDBP ALS‐causative mutations—these results warrant more comprehensive transcriptomic studies in patient‐derived material, which are currently lacking for TARDBP ALS mutations.